Accelerating Clinical Trials with AI-Powered Biomarker Detection
AI imaging that detects biomarkers with greater speed and accuracy. Machine learning and computer vision improve early identification of biological indicators — streamlining patient selection, monitoring, and analysis, and shortening trial timelines so treatments reach market sooner.